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Abstract 
This report describes a method for integration of a gel-liquid interface in hollow 
microneedles compatible with minimally invasive, electrochemical detection of drugs 
in vivo. The electrochemical sensor was characterised using cyclic voltammetry of 
tetraethyl ammonium. The experimental work demonstrated the detection of 
propranolol as a representative drug in physiological buffer with the microneedle 
system.  A calibration curve for propranolol was built from measurements with 
differential pulse stripping voltammetry, indicating a sensitivity of 43 nA µM-1, a limit 
of detection of 50 nM and a linear range between 50 – 200 nM.  
Keywords 
Microneedles, micro-interfaces, ITIES, -blocker drug, minimally invasive, stripping 
voltammetry. 
  
1. Introduction 
 
The past 20 years have seen the development of microneedles as an alternative to 
traditional subcutaneous needles for transdermal delivery of substances that are of 
medical interest. Microneedles have been used for the delivery of pharmacological 
compounds [1] and for vaccination [2, 3]. Research efforts have also been devoted 
to extend the use of microneedles beyond their traditional purpose of drug delivery, 
as it was the case in the use of metalized microneedles for electroporation therapy 
[4].  
Hollow microneedles applied onto the skin are able to extract interstitial fluid [5, 6], 
offering a solution for a minimally invasive sensor of biomarkers in bodily fluids. 
However, detection of biomarkers of interest is done off-line [7], which requires the 
extraction of interstitial fluid from the body. Regardless of the method of extraction, 
the concept is hindered by the need of high vacuum pressures (200-500 mm Hg) for 
the extraction and collection of fluid [6]. Additionally, the volumes of fluid collected 
are variable [6, 8] and little is known of the reliability of extraction in a continuous 
basis. In conclusion, the complexity of a sensor able to provide continuous 
information of biochemical analytes in a physiological fluid would be drastically 
reduced with a design that did not require the uptake of biological fluids.  
The use of electrochemical sensors can be a solution for an on-line detection without 
the need of sample extraction. Furthermore, miniaturised electrochemical sensors 
are more sensitive than macroscopic sensors [9] and electrochemical 
instrumentation is relatively easily miniaturised [10]. Recently, hollow polymeric 
microneedle arrays were filled with microelectrodes and used for the amperometric 
detection of hydrogen peroxide, lactate, glutamate and glucose [11, 12]. 
We report here a novel sensor based on an array of hollow microneedles filled with 
an organogel able to sense ionic species in a physiological fluid. This platform takes 
advantage of the possibility to polarise the interface formed between the organogel, 
located inside the hollow microneedle, and the physiological fluid. Electrochemical 
sensors based on micro-interfaces between two immiscible electrolyte solutions 
(µITIES) have been developed in recent years [13, 14]. This electrochemical 
technique is based on ions transferring across a polarized liquid-gel interface upon 
application of a potential difference. Ion transfer from one phase to another gives rise 
to a current that can be monitored. Silicon-based micro and nano ITIES have been 
developed for the detection of analytes that are not redox active molecules [15, 16]. 
Examples like detection of dopamine [17] and peptides [18, 19] show the potential of 
this technique as an alternative to traditional electrochemical techniques.  
We propose the use of a novel diagnostic platform that combines a hollow 
microneedle array with electrochemical detection at µITIES. The presence of the 
µITIES in the inner bore of the microneedles offers several advantages: it avoids the 
need of fluid extraction, as the ions cross the gel-liquid interface due to the potential 
difference applied at the interface; additionally, the reduced dimensions of the 
interface enhance rapid diffusion of species, which improves detection limits of the 
analytes. This effect is illustrated in different works on µITIES [18-21] and even used 
for the development of bioanalytical sensors [22].  
We have selected propranolol as a model analyte. This drug belongs to the β-
adrenergic blocking group [23]; it reduces heart rate and blood pressure, which 
makes it useful for treatment of hypertension and chest pain related to heart failure 
(angina) [23]. Blood pressure and heart rate correlate with propranolol levels in 
plasma [24]. Therefore, its direct measure in a physiological matrix could be useful 
for correct drug dosage and the monitoring of patient response to treatment. 
Propranolol has already been detected by ion transfer voltammetry at µITIES at 
concentration levels that are physiologically relevant [25-27], thus allowing useful 
comparison with the results reported here.  
We present also the characterisation of the silicon microneedle system by scanning 
electron microscopy (SEM) and cyclic voltammetry (CV) of tetraethyl ammonium 
(TEA+). This model analyte has been used extensively in the characterization of 
ITIES, as it presents rapid and mechanistically simple transfers in these systems [28-
31]. The array is then used for the detection of propranolol in physiological medium 
by differential pulse stripping voltammetry (DPSV). 
 
  
2. Material and methods 
 
2.1. Reagents 
All the reagents were purchased from Sigma-Aldrich Ireland Ltd. and used as 
received except for 1,6-dichlorohexane (1,6-DCH) (Merck), that was purified 
according to the published procedure [32]. The organic electrolyte salt was prepared 
by metathesis of bis-(triphenylphosphoranylidene) ammonium chloride (BTPPA+ Cl-) 
and of potassium tetrakis(4-chlorophenyl)-borate (K+TPBCl-) to obtain BTPPATPBCl, 
following the published experimental procedure [33]. The organogel phase was 
prepared using purified 1,6-DCH and low molecular weight polyvinylchloride (PVC) 
10:1 (v:w) [14]. For the experiments of propranolol detection at the µITIES array, the 
aqueous phase was composed of magnesium pyrophosphate (1.6 mg L-1), 
carboxymethyl cellulose (4 g L-1), urea (4 g L-1), disodium hydrogen phosphate (0.6 g 
L-1), anhydrous calcium chloride (0.6 g L-1), potassium chloride (0.4 g L-1), and 
sodium chloride (0.4 g L-1). 
 
2.2. Microneedle array-µITIES 
The silicon microneedle arrays were fabricated using a combination of potassium 
hydroxide (KOH) wet-etching and Bosch dry-etching techniques [34, 35]; the final 
microneedle array is shown in the scanning electron micrograph of figure 1A. Briefly, 
square oxide/nitride masks were patterned using standard photolithography tools on 
a <100>, boron doped, 100 mm diameter monocrystalline silicon wafer. These 
masks are aligned with the <110> direction and the patterned silicon wafer is then 
etched in a 29 % w/v aqueous KOH solution. Convex corner mask undercut takes 
place, leading to the formation of two angled planes at each corner, which eventually 
intersect to form an octagonal microneedle. This needle is comprised of eight {263} 
planes, a base of {212} planes and has a height to base aspect ratio of 3:2.  
To form hollow bores through the microneedles, a 3 µm Plasma-Enhanced Chemical 
Vapour Deposition (PECVD) oxide layer is deposited and patterned on the rear of 
the wafer to act as a hard mask; a 2 µm layer of aluminium is sputtered on the front 
side of the wafer to act as an etch stop layer. 50 µm diameter capillary conduits are 
then micromachined from the back side of the wafer using a Surface Technology 
System (STS) ASE ICP dry etching tool incorporating Bosch dry etching technology; 
the etch gases are SF6 and C4F8. Afterwards, the aluminium layer and thick oxide 
layers are stripped from the front and back sides of the wafer, respectively. 
In the case of the array used, the 300 µm high microneedles were separated by 1 
mm. The bore is of a cylindrical shape with a diameter comprised between 55 and 62 
µm as it is shown on the scanning electron microscope (SEM) image of figure 1A.  
 
Figure 1: (A) SEM image of an array of hollow silicon microneedles. (B) Optical micrograph of the cross-section 
of a microneedle filled with the organogel. The microneedle system was encased in epoxy glue in order to 
facilitate subsequent slicing of the silicon material. 
 
The creation of a micro ITIES at the microneedles is done by filling their bores with 
the organogel.  A glass cylinder of 9 mm of inner diameter was sealed to the back of 
the microneedle array with silicone rubber. This configuration encloses a total of 52 
hollow microneedles available for the experiments. The fabricated needles feature 
hydrophobic walls, which allowed an easy filling of the microneedle holes with the 
organogel; the latter had been heated gently at 50 °C in order to reduce its viscosity. 
The filling was done by pipetting the organogel onto the back of the microneedle 
array. Once the holes were filled (see figure 1B), the array was left to rest for at least 
1 h before proceeding with the experiments. 
 
2.3. Electrochemical set-up 
 
In order to perform the electrochemical measurements, the system was configured 
as shown in figure 2.  
 
Figure 2: Experimental set up for electrochemical measurements. The aqueous phase consists of an Ag/AgCl 
wire and a meshed Pt wire as reference and counter electrodes respectively. Both are immersed in a solution 
with the analyte to be detected. As for the organic phase, a Ag/AgCl electrode behaves as both the reference and 
counter electrode. 
The aqueous phase electrodes consisted of a platinum mesh counter electrode and 
a Ag/AgCl reference electrode. A Ag/AgCl wire acted as both the reference and 
counter electrode in the organic phase. The Ag/AgCl wires were prepared by 
oxidation of silver wires in a solution of FeCl3. The aqueous phase electrodes are 
immersed in the beaker containing the aqueous solution, always clearly separated 
from each other. The electrode for the organic phase is immersed in the organic 
reference solution (BTPPA+TPBCl-). Finally, the microneedle-gel array is placed in 
the aqueous solution, making sure that the needles are completely immersed in the 
solution. Two electrochemical cells were used for these experiments. The first one, 
for the characterisation of the microneedle array by TEA+ cyclic voltammetry, was as 
follows: Ag | AgCl | Saturated BTPPA+Cl- in 10 mM LiCl | 10 mM BTPPA+TPBCl- in 
1,6 DCH-PVC organogel || 160 µM TEA+ in 10 mM LiCl | AgCl | Ag. A second 
electrochemical cell was used for the detection of propranolol: Ag | AgCl | Saturated 
BTPPA+Cl- in 10 mM LiCl | 10 mM BTPPA+TPBCl- in 1,6 DCH-PVC organogel || 
different concentrations of propranolol in physiological buffer | AgCl | Ag.  
 
For all experiments, the electrodes were connected to a CHI660B electrochemical 
analyser (CH Instruments, Texas, purchased from IJ Cambria, Burry Port, Wales, 
United Kingdom). Cyclic voltammetry was used as characterisation method, and 
differential pulse stripping voltammetry (DPSV) was chosen as the analytical 
detection method. The stripping method consisted of three steps: (i) preconditioning, 
(ii) preconcentration and (iii) detection. First, the ITIES went through an optimised 
preconditioning step during which a potential of 0.45 V was maintained for 120 s to 
clean the gel from any residuals of the analyte that may remain from a previous 
experiment. A preconcentration step was then used to transfer the analyte from the 
aqueous phase to the organic phase; the potential was held at 0.86 V for a period 
between 15 and 240 s to transfer the analytes to the organogel. These two steps 
allow concentrating the propranolol in the organogel. Finally, the detection step 
consisted of the back transfer of the preconcentrated propranolol to the aqueous 
phase by the scanning of a predefined potential window. The parameters for DPSV 
were: amplitude = 80 mV; pulse width = 0.1 s; sample width = 0.05 s; pulse period = 
0.2 s. This DPSV protocol has been described previously [25]. 
 
3. Results and discussion 
 
3.1. System characterization by cyclic voltammetry analysis 
 
The electrochemical response of the hollow microneedle system was characterized 
by ion transfer voltammetry of the model analyte tetraethyl ammonium cation (TEA+) 
at the ITIES formed in the bore of the needles. Before proceeding with any 
experiments, we determined the optimal scan rate values for the geometry of the 
needle array. The diffusion layer thickness (δ) should ideally be larger than the 
µITIES formed in the microneedles bores but not as large as to cause adjacent 
diffusion layers to overlap. This condition is highly desired as it results in the 
maximum faradaic current to background current ratio. To ensure non-overlapping 
diffusion areas between the holes of the array, it is sufficient to have 𝑑 > 2𝛿 [36], d 
being the distance of the holes from centre to centre.  
 
The diffusion area can be approximated by Einstein’s equation for the root mean-
square displacement of diffusing particles with Brownian motions:  
 
𝛿 =  √2𝐷 ∆𝐸 𝜈⁄       (1) 
 
In eq. (1), D is the diffusion coefficient (m2 s-1); ΔE is the difference of potential 
between the onset of electrolysis and the peak of limiting current (V);   is the scan 
rate (V s-1). The substitution of this expression in the aforementioned condition for 
independent diffusion layers leads to the following equation for the scan rate:   
𝝂 > 𝟖𝑫 𝜟𝑬 𝒅𝟐⁄                        (2) 
In the particular case of our experiments, eq. (2) gives  = 2.35 mV s-1 as the lower 
limit that present radial diffusion with no overlapping areas (taking D = 9.8·10-6 cm2 s-
1 for TEA+ and ΔE = 0.3 V). All the experimental work was carried out with  values 
higher than this limit. Therefore, the distance between adjacent microneedles (20 
times the radius of the inner needle bore) is sufficiently large to avoid overlapping of 
the diffusion layer. 
 
Figure 3A shows the cyclic voltammogram in the absence and in the presence of 
TEA+ in the aqueous phase. In the absence of TEA+, the potential window is limited 
by the transfer of the background electrolytes, noticeable in the steep variations of 
current at potentials greater than + 0.9 V and lower than + 0.2 V. The capacitance at 
+ 0.6 V was estimated to be of (16.46 ± 0.40) µF cm-2.  
With the experiments conditioned as by the above calculations, asymmetry in the 
CVs was expected, as it has already been observed in a number of µITIES systems 
[37]. In these reported cases, a sigmoidal wave is observed in the forward scan, 
which results from the radial diffusion of species in the aqueous phase. On the other 
hand, the reverse scan showed a peak that corresponded to the linear diffusion of 
species inside the pores.  
According to this, the microneedle system should present a steady state response 
during the forward sweep in the form of a sigmoidal curve for the TEA+ transfer. 
However, as shown in figure 3A, it is hard to distinguish the TEA+ transfer from the 
background electrolyte transfer. This could be explained by the hindered diffusion 
towards the interface. The bore of the microneedle is not centred but slightly shifted 
to the side as it is shown in figure 1A and schematically represented in figure 3B. As 
a consequence, diffusion of species towards the micro-interface is not hemispherical 
as it can be observed at regular disk micro-interfaces. It presents a diffusion profile 
mixed between radial and linear as represented by the arrows in figure 3B.  
 
Figure 3: (A) Cyclic voltammetry curves in the presence (black) and in the absence (grey) of 160 µM TEA+. The 
scan rate was 3.5 mV s-1. (B) Schematic representation of the top view and side views of a microneedle filled with 
an organogel. The arrows represents the diffusion of species in the aqueous phase towards the organogel.  
 
By contrast, the reverse sweep presents a peak-shaped voltammogram indicating a 
diffusion-controlled return of the analyte from the organic to the aqueous phase (see 
again figure 3). This was further corroborated by subsequent experiments where the 
scan rate was varied between 5 and 17 mV s-1 (see figure 4). The measured reverse 
peak current is directly proportional (with R2=0.997) to the square root of the scan 
rate, which confirms the presence of the diffusion-controlled process when TEA+ 
transfers back to the aqueous phase. 
 
Figure 4: CVs of 160 µM TEA+ in 10 mM LiCl, at increasing values of  (5, 6, 7, 8, 9, 10, 11, 12, 15 and 17 mV/s; 
from light green to black, respectively). (Inset) Reverse current peaks against square root of . The peaks 
present a linear slope with the square root of , which is a typical response of diffusion-prevailing systems 
(R2=0.997). 
The gel phase forms a recessed interface at the aqueous side of the ITIES (as it can 
be seen in figure1B).  Computational simulations have shown that this configuration 
is optimal for stripping voltammetry, as transport of analyte species to the gel micro-
interface improves with a hemispherical diffusion regime during the preconcentration 
step [38] . Once they are transferred to the organic phase, they remain in the vicinity 
of the interface because of the reduced mass transport caused by both the linear 
diffusion and the lower diffusion coefficient in the PVC gel. Simulation studies have 
shown that the diffusion coefficient of TEA+ was estimated to be nine times lower in 
the gel phase than in the aqueous solution  [39].  
3.2. Voltammetric detection of propranolol at the microneedle array 
 
Figure 5 shows the CV of propranolol at the liquid-gel interface supported by the 
microneedle array. A sigmoidal wave is observed at + 0.7 V for the transfer of 
propranolol from the aqueous to the organic phase, whereas a peak is observed at + 
0.25 V for the back transfer. The CV from propranolol shows the same features than 
with the experiments with TEA+: hemispherical diffusion during the forward scan, and 
linear diffusion on the reverse sweep.  
 
Figure 5: CV of 100 µM propranolol (black) and background electrolyte (grey). scan rate was 35 mV s-1) 
The CV behaviour allows us to use eq. (3) to calculate the radius of the microneedle 
bore based on the propranolol limiting current, ilim, measured on the forward scan. 
 
𝑖𝑙𝑖𝑚 = 𝑛4𝑧𝐹𝐷𝐶𝑟     (3) 
 
This equation defines the limiting current that is expected for an array of disc 
interfaces, where n is the number of microneedle interfaces (n = 52); z is the number 
of charge transferred (z = 1); F is the Faraday constant; D is the diffusion coefficient 
(D = 1.15 × 10-5 cm2 s-1, [40]); C is the propranolol concentration (C = 100 × 10-9 mol 
cm-3) and r is the radius in cm. The theoretical limiting current of 57 nA (from 
equation 3) agrees well with the experimental value of 55 ± 3 nA (measured in CVs 
modified with background subtraction, not shown) corresponds to a microneedle 
interface radius of 25 µm, which agrees with the radius suggested by the SEM 
images (figure 1).  
 The use of differential pulse stripping voltammetry (DPSV) as the analytical 
technique offers the possibility to detect lower concentrations of the analyte as 
capacitive/background current is eliminated.  
Figure 6 shows the DPSVs for increasing preconcentration times ranging from 15 to 
240 s. Stripping peak currents increase slowly with the preconcentration time. 
Noticeably, the stripping peak current after 240 s of preconcentration is 
approximately 5 times higher than the one measured for 15 s. Based on these 
results, a preconcentration time t = 240 s was selected for the rest of experiments, 
as it provided the maximum current peak that was recorded.  
 
Figure 6:(A) DPSVs of 100 µM propranolol for increasing preconcentration times: 15, 30. 45, 
60, 90, 120, 180, 210, 240 s. (B) Stripping peak current as a function of the preconcentration 
time 
Once the preconcentration step was defined, DPSVs for increasing concentrations of 
propranolol in aqueous solution were recorded (figure 7A). The stripping peak (figure 
7B) increased linearly with propranolol concentrations within the range 50 – 200 nM. 
A sensitivity of 43 nA µM-1 was calculated as the slope of the calibration curve (R2 = 
0.99423).  
 Figure 7: (A) DPSVs of different concentrations of propranolol in artificial saliva (propranolol concentrations, from 
lightest grey to black: 0.03, 0.05, 0.07, 0.09, 0.11, 0.13, 0.15, 0.17, 0.2, 0.4, 0.6,0.8 and 1 µM). (B) Current 
calibration curve for DPSVs of propranolol. Lower concentrations show a marked behaviour typical of spherical 
diffusion (a steep sloped line), whereas higher concentrations (typically, from 200 nM onwards) present a linear 
diffusion progress (flat line). R2= 0.994. 
The stripping peak for propranolol shifts towards less positive potential values as the 
preconcentration time or the concentration increase. This could be explained by two 
different phenomena (or a combination of both): (i) the kinetic limitation due to the 
increasing amounts of propranolol back-transferring or (ii) the uncompensated 
resistance due to an increasing ohmic drop. At concentrations higher than 200 nM, 
the stripping peak currents present a saturation effect. This could be justified by the 
fact that diffusion of propranolol is reduced due to the viscosity of the gel. The lowest 
concentration that the system was able to detect was 50 nM, which is within the 
detection limits published for propranolol [25, 43-46]. 
 
4. Conclusions 
 
This report presents for the first time the development of a microneedle array with an 
embedded µITIES platform that is electrochemically able to detect propranolol. 
Although there is a wealth of literature reporting the use of µITIES for 
electrochemical detection, previous works were based in the use of micropipettes or 
arrays of micro and nano-holes as support structures for the miniaturized ITIES.  
The array of sensors was capable of detecting propranolol in artificial saliva with 
good sensitivity and a limit of detection that is of pharmacological relevance. The use 
of miniaturized interfaces and DPSV as the analytical method of detection deliver a 
low limit of detection, 50 nM, which compares well with previously published results 
for propranolol. This includes 0.2 μM with adsorptive stripping differential pulse 
voltammetry [47]; 5 μM  for potentiometric membrane electrode [45]; 0.02 μM with 
cathodic adsorptive stripping voltammetry [48]; 0.1 μM for capillary electrophoresis 
[49]. The platform presents a linear range between 50 and 200 nM.  
 
Our future line of work will address the application of the microneedle-µITIES system 
to the detection of biomarkers for in vivo applications. The characteristics of the 
microneedle-ITIES could be beneficial in a scenario for transdermal analysis, as the 
system can overcome the skin barrier with minimal pain (thanks to the microneedles) 
and without physiological fluid extraction (due to the µITIES embedded). 
Nevertheless, the chemicals used for the organogel are toxic and will not be used as 
such for in-vivo applications. Future developments will need the investigation of new 
materials for the organic phase. We will look into compounds that present both 
biocompatibility and stability in the long term (the organogel presently used is volatile 
at air atmosphere and degrades slowly with time). 
Additionally, even though the presence of the organogel in the bore of the needles 
should avoid potential clogging in transdermal applications, we will study this issue 
during future experimental work. 
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Captions 
Figure 1: (A) SEM image of an array of hollow silicon microneedles. (B) Optical micrograph of the cross-section 
of a microneedle filled with the organogel. The microneedle system was encased in epoxy glue in order to 
facilitate subsequent slicing of the silicon material.  
Figure 2: Experimental set up for electrochemical measurements. The aqueous phase consists of an Ag/AgCl 
wire and a meshed Pt wire as reference and counter electrodes respectively. Both are immersed in a solution 
with the analyte to be detected. As for the organic phase, a Ag/AgCl electrode behaves as both the reference and 
counter electrode. 
Figure 3: (A) Cyclic voltammetry curves in the presence (black) and absence (grey) of 160 µM TEA+, for an array 
of 56 micropores/needles. The scan rate was 35 mV s-1.  (B) Schematic representation of the top view and side 
views of a microneedle filled with an organogel. The arrows represent the diffusion of species in the aqueous 
phase towards the organogel. The addition of 160 µM TEA+ to the aqueous solution leads to an increase of the 
current starting from + 0.6 V, indicating the TEA+ transfer. On the reverse scan, a peak is visible at + 0.4 V, 
corresponding to the transfer of the TEA+ from the organic phase back to the aqueous phase.  
Figure 4: CVs of 160 µM TEA+ in 10 mM LiCl, at increasing values of (5, 6, 7, 8, 9, 10, 11, 12, 15 and 17 mV s-1; 
from light green to black, respectively). The experiments correspond to an array of needles with 56 micropores. 
(Inset) Reverse current peaks against square root of . The peaks present a linear slope with the square root of 
, which is a typical response of diffusion-prevailing systems (R2=0.997). 
Figure 5: CV of 100 µM propranolol (black) and background electrolyte (grey). Scan rate was 8 mV s-1). 
Figure 6: (A), DPSVs of 100 µM propranolol for increasing preconcentration times: 15, 30. 45, 60, 90, 120, 180, 
210, 240 s. (B), Stripping peak current as a function of the preconcentration time. 
Figure 7: (A) DPSVs of different concentrations of propranolol in artificial saliva. (B) Corresponding current 
calibration curve for DPSVs of propranolol. Measurements were performed for the following concentrations of 
propranolol: 0.03, 0.05, 0.07, 0.09, 0.11, 0.13, 0.15, 0.17, 0.2, 0.4, 0.6, 0.8 and 1 µM (figure A shows a selection 
of plots for visual clarity, corresponding to concentrations of propranolol of 0.07, 0.09, 0.11, 0.15, 0.17, 0.2, 0.8 
and 1 µM).  Lower concentrations show a marked behaviour typical of spherical diffusion (a steep sloped line), 
whereas higher concentrations (typically, from 200 nM onwards) present a linear diffusion progress (flat line). R2= 
0.994. 
